Effect of dodecylmaltoside (DDM) on uptake of BCS III compounds, tiludronate and cromolyn, in Caco-2 cells and rat intestine model

Drug Delivery

Volumn 17, Issue 3, 2010, Pages 145-151

  Deshmukh, Deepali D ^a,b   Nagilla, Rakesh ^a,b   Ravis, William R ^a   Betageri, Guru V ^c  

^a AUBURN UNIVERSITY   (United States)

^b GLAXOSMITHKLINE   (United States)

^c WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

Author keywords

BCS III; Caco 2; Dodecylmaltoside; Everted intestinal sacs; Permeation enhancer

Indexed keywords

CROMOGLYCATE DISODIUM; DODECYLMALTOSIDE; LUCIFER YELLOW; PYRANOSIDE; TILUDRONIC ACID; UNCLASSIFIED DRUG; WATER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CANCER CELL; CELL STRAIN CACO 2; COLON ADENOCARCINOMA; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG EFFICACY; DRUG PENETRATION; DRUG TRANSPORT; DRUG UPTAKE; HUMAN; HUMAN CELL; INTESTINE; INTESTINE INJURY; MALE; MODEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SAMPLE; SEROSA;

ALGORITHMS; ANIMALS; BONE DENSITY CONSERVATION AGENTS; CACO-2 CELLS; CELL MEMBRANE; CROMOLYN SODIUM; DETERGENTS; DIPHOSPHONATES; FLUORESCENT DYES; GLUCOSIDES; HUMANS; INTESTINAL ABSORPTION; ISOQUINOLINES; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 77949597863     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717541003604882     Document Type: Article

References (29)

1. Allen, A. (1981). Structure and function of gastrointestinal mucus. In Johnson, L.R., ed. Physiology of the gastrointestinal tract. New York: Raven Press, 617-639
2. Anderson, J.M., Van Itallie, C.M. (1995). Tight junctions and the molecular basis for regulation of paracellular permeability. Am J Physiol. 269:467-475
3. Artursson, P., Palm, K., Luthman, K. (2001). Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv Drug Del Rev. 22:67-84.
4. Aungst, B.J. (1994). Site-dependence and structure-effect relationships for alkylglycosides as transmucosal absorption promoters for insulin. Int J Pharm. 105:219-1115
5. Barthe, L., Woodley, J.F., Kenworthy, K., Houin, G. (1998). An improved everted gut sac as a simple and accurate technique to measure paracellular transport across the small intestine. Eur J Drug Metabol Pharmacokinet. 2:313-323
6. Boulenc, X., Breul, T., Gautier, J-C., Saudemon, P., Joyeux, H., Roques, C., Berger, Y., Fabre, G. (1995). Sodium lauryl sulphate increases tiludronate paracellular transport using human epithelial Caco-2 monolayers. bisphosphonate using the human Caco-2 monolayers model. Int J Pharm. 123:71-83.
7. Boulenc, X., Marti, E., Joyeux, H., Roques, C., Berger, Y., Fabre, G. (1993). Importance of the paracellular pathway for the transport of a new bisphosphonate using the human Caco-2 monolayers model. Biochem Pharmacol. 46:1591-1600
8. Davi, H., Tronquet, C., Caix, J., Simiand, J., Briot, C., Berger, Y., Thiercelin, J.F. (1999). Disposition of tiludronate (Skelid) in animals. Xenobiotica. 10:1017-1031
9. Delie, F., Rubas, W. (1997). A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: advantages and limitations of the Caco-2 model. Crit Rev Ther Drug Carrier Syst. 14:221-286
10. Hidalgo, I.J., Raub, T.J., Borchardt, R.T. (1989). Characterization of human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology. 96:736-749
11. Hilgers, A.R., Conradi, R.A., Burton, P.S. (1990). Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa. Pharm Res. 7:902-910
12. Leone-Bay, A., Leipold, H., Sarubbi, D., Variano, B., Rivera, T., Baughman, R.A. (1996). Oral delivery of sodium cromolyn: preliminary studies in vivo and in vitro. Pharm Res. 13:222-225
13. Leppert, P.S., Fix, J.A. (1994). Use of everted intestinal rings for in vitro examination of oral absorption potential. J Pharm Sci. 83:976-998
14. Meaney, C., O'Driscoll, C. (1999). Mucus as a barrier to the permeability of hydrophilic and lipophilic compounds in the absence and presence of sodium taurocholate micellar systems using cell culture models. Eur J Pharm Sci. 8:167-175.
15. Mineo, H., Hara, H., Shigematsui, N., Okuhara, Y., Tomita, F. (2002). Melibiose, difructose anhydride III and difructose anhydride IV enhance net calcium absorption in rat small and large intestinal epithelium by increasing the passage of tight junctions in vitro. J Nutr. 132:3394-3399
16. Murakami, M., Kusanoi, Y., Takada, K., Muranishi, S. (1992). Assessment of enhancing ability of medium-chain alkyl saccharides as new absorption enhancers in rat rectum. Int J Pharm. 79:159-169
17. Pillion, D.J., Hosmer, S., Meezan, E. (1998). Dodecylmaltosidemediated nasal and ocular absorption of Lyspro-insulin: independence of surfactant action from multimer dissociation. Pharm Res. 15:1637-1639
18. Pinto, M., Ronnie-Leon, S., Appay, M.D., Kidinger, M., Triadov, N., Dussaulx, E., Lacroix, B., Simon-Assmann, P., Hoffen, K., Fogh, J., Zwiebaum, A. (1983). Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 culture. Biol Cell. 147:323-330
19. Ravis, W.R., Feldman, S. (1978). Effect of enzyme-inducing and enzyme-inhibiting agents on drug absorption I: 3-O-methylglucose transport in rats. J Pharm Sci. 67:245-248
20. Ruifrok, P.G., Mol, W.E.M. (1983). Paracellular transport of inorganic and organic ions across the rat ileum. Biochem Pharmacol. 32:637-640
21. Sasaki, I., Tozaki, H., Matsumoto, K., Ito, Y., Fujita, T., Murakami, M., Muranishi, S., Yamamoto, A. (1999). Development of an oral formulation of azetirelin, a new thyrotropin-releasing hormone analog using n-lauryl-b-(D)-maltopyranoside as an absorption enhancer. Biol Pharm Bull. 22:611-615
22. Tanaka, Y., Taki, Y., Sakane, T., Nadai, T., Sezaki, H., Yamashita, S. (1995). Characterization of drug-transport through tight-junctional pathway in Caco-2 monolayer: comparison with isolated rat jejunum and colon. Pharm Res. 2:523-528
23. Tidball, C.S., Lipman, R.I. (1962). Enhancement of jejunal absorption of heparinoid by sodium ethylenediaminetetraacetate in the dog. Proc Sot Exp Biol Med. 111:713-715
24. Tirumalasetty, P.P., Eley, J.G. (2004). Evaluation of dodecylmaltoside as a permeability enhancer for insulin using human carcinoma cells. J Pharm Sci. 94:246-255
25. Uchiyama, T., Yamamoto, A., Hatano, H., Fujita, T., Muranishi, S. (1996). Effectiveness and toxicity screening of various absorption enhancers in the large intestine: intestinal absorption of phenol red and the protein and phospholipid release from the intestinal membrane. Biol Pharm Bull. 19:1618-1621
26. Weber, N., Benning, H. (1984). Metabolism of orally administered alkyl b-glycosides in the mouse. J Nutr. 114:247-254
27. Wilson, G. (1990). Cell culture techniques for the study of drug transport. Eur J Drug Metab Pharmacokinet. 15:159-163
28. Yamamoto, A., Okagawa, T., Kotani, A., Uchiyama, T., Shimura, T., Tabata, S., Kondo, S., Muranishi, S. (1997). Effects of different absorption enhancers on the permeation of ebiratide, an ACTH analog, across intestinal membranes. J Pharm Pharmacol. 49:1057-1061
29. Yamamoto, A., Uchiyama, T., Nishikawa, R., Fujita, T., Muranishi, S. (1996). Effectiveness and toxicity screening of various absorption enhancers in the rat small intestine: effects of absorption enhancers on the intestinal absorption enhancers on the intestinal absorption of phenol red and the release of protein and the intestinal membrane. J Pharm Pharmacol. 48:1285-1289